ReviewCureus2026
Gender-Specific Disparities in Outcomes of Transcatheter Aortic Valve Implantation/Repair in Patients With Aortic Stenosis: A Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aortic stenosis caused by calcification and sclerosis of the left ventricular outflow tract is a life-threatening condition associated with a high risk of heart failure. Transcatheter aortic valve replacement (TAVR) is the definitive treatment for this condition. Gender-specific disparities influence post-procedural recovery, as women, despite generally having better long-term survival, have higher risks of short-term mortality, vascular complications, and major bleeding. Understanding these differences is essential for better post-operative care. We performed a comprehensive literature search of PubMed, Google Scholar, and the Cochrane Library using the keywords "Gender Disparities," "TAVR," "Aortic Stenosis," and "TAVI." Studies published between 2015 and 2025 were screened, yielding 25 eligible studies. Quality assessment was conducted using the Newcastle-Ottawa Scale for cohorts and the Cochrane risk-of-bias tool for randomized controlled trials. Overall, the included studies demonstrated moderate to high methodological quality, ensuring reliability of the findings. Female patients undergoing TAVR showed better long-term survival, with seven studies reporting higher all-cause mortality in females (p <0.05) and six reporting a significantly higher mortality in males (p<0.05). Stroke and MACE outcomes were mixed; some studies reported a higher incidence in females (p<0.05), whereas others found no significant difference (p > 0.05). Females had significantly higher rates of vascular complications, major or life-threatening bleeding (p<0.05), and a smaller aortic valve annulus. Secondary outcomes, including new pacemakers and non-home discharge, showed variable significance between genders. Women undergoing TAVR demonstrate better long-term survival despite higher rates of vascular complications and bleeding. Further research is needed to confirm these gender-related differences and guide post-procedural management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.